Mariner
EDIT icon

Mariner’s Editas Medicine EDIT Stock Holding History

Mariner’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$359K Buy
145,540
+104,219
+252% +$221K ﹤0.01% 2717
2025
Q4 		$84.7K Sell
41,321
-36,094
-47% -$104K ﹤0.01% 3355
2025
Q3 		$269K Buy
77,415
+23,675
+44% +$66.1K ﹤0.01% 2912
2025
Q2 		$118K Buy
53,740
+31,959
+147% +$52.3K ﹤0.01% 3203
2025
Q1 		$25.3K Buy
+21,781
New +$32K ﹤0.01% 3357
2024
Q4 		– Sell
-11,554
Closed -$39.4K – 3418
2024
Q3 		$39.4K Buy
+11,554
New +$50.3K ﹤0.01% 3213
2024
Q2 		– Sell
-16,389
Closed -$122K – 3207
2024
Q1 		$122K Buy
+16,389
New +$136K ﹤0.01% 2893

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return